6-amino-1-hydroxyhexane-1,1-diphosphonate and Bone Diseases, Metabolic

6-amino-1-hydroxyhexane-1,1-diphosphonate has been researched along with Bone Diseases, Metabolic in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Adami, S; Fracassi, E; Gatti, D; Idolazzi, L; Viapiana, O	1
Chambers, TJ; Gallagher, AC; Laversuch, CJ; Tobias, JH	1

Reviews

1 review(s) available for 6-amino-1-hydroxyhexane-1,1-diphosphonate and Bone Diseases, Metabolic

Article	Year
Neridronic acid for the treatment of bone metabolic diseases. Expert opinion on drug metabolism & toxicology, 2009, Volume: 5, Issue:10 Topics: Adult; Bone Diseases, Metabolic; Child; Child, Preschool; Clinical Trials as Topic; Diphosphonates; Drug Evaluation, Preclinical; Humans; Infant; Infant, Newborn; Italy; Osteitis Deformans; Osteogenesis Imperfecta	2009

Trials

1 trial(s) available for 6-amino-1-hydroxyhexane-1,1-diphosphonate and Bone Diseases, Metabolic

Article	Year
Aminohexane bisphosphonate suppresses bone turnover in postmenopausal women more rapidly than oestrogen-gestagen therapy. British journal of rheumatology, 1996, Volume: 35, Issue:7 Topics: Adult; Alkaline Phosphatase; Amino Acids; Biomarkers; Bone and Bones; Bone Diseases, Metabolic; Creatinine; Diphosphonates; Estrogens; Female; Humans; Middle Aged; Osteocalcin; Postmenopause; Progestins; Time Factors	1996

Article

Year

Aminohexane bisphosphonate suppresses bone turnover in postmenopausal women more rapidly than oestrogen-gestagen therapy.

British journal of rheumatology, 1996, Volume: 35, Issue:7

Topics: Adult; Alkaline Phosphatase; Amino Acids; Biomarkers; Bone and Bones; Bone Diseases, Metabolic; Creatinine; Diphosphonates; Estrogens; Female; Humans; Middle Aged; Osteocalcin; Postmenopause; Progestins; Time Factors

1996